Welcome to the current edition of i2P (Information to Pharmacists) E-Magazine dated Monday 23 July 2018.
Since our last edition we have seen mainstream media (MSM) focus on US president Donald Trump lambasting him for protocol breaches (walking in front of Queen Elizabeth), and calls for impeachment on a charge of treason.
While this bizarre reporting is unsettling, given the influence the US has in Australia, we are not getting honest answers or investigation from even our own mainstream media.
Did Donald Trump collude with Russia to win the last election?

It seems highly unlikely, but given the turmoil that US politics has become, anything is possible.
To find answers you have to turn to the network of independent media online publishers to gain insight and understanding.
They are reporting that the outrage being pushed by mainstream media is an attempt to distract from “the political bombshell of the century” – the one alluded to by Vladimir Putin, that a Russian-linked business mogul sent $400,000 to the Hillary Clinton campaign and that the money was laundered tax free by US intelligence officials working for Obama.
And since that announcement, mainstream media has been desperately trying to distract the public from this stunning revelation by wildly accusing Trump of treason for merely talking to Putin while seeking peace rather than nuclear war.
It is speculated by independent media that Putin may have detailed information that could lead to the arrest and prosecution of Hillary Clinton and Barack Obama, plus a range of intelligence agents, and that he may already have given this information to Trump.

The Gateway Pundit is one independent media organisation following this issue, and asks:
“So why are the Democrats, the Deep State and the MSM so petrified of President Trump meeting with Putin? 
The answer is because they are deathly afraid of not what Putin might tell Trump but what evidence Putin might have that would indict their leaders in prior criminal actions.” 
“The Democrats, the MSM and Deep State are in a complete panic!
Obama gang members came out of hiding and screamed with fear over what Trump may have learned from Putin, so much so that they claimed President Trump should be impeached.”

We now hear that Vladimir Putin has been invited to the White House for return discussions.
I wonder if this will include Putin bringing hard evidence with him regarding the activities noted above.

Other independent media organisations are separately confirming the existence of a “Russiagate” with Obama centrally connected to a corrupt group of intelligence agents.
Given that it is this same “Deep State” group driving corrupt interests associated with Big Pharma, especially vaccination policy, it is hoped that President Trump does have information that will eventually break the hold of this corrupt power group and that Australian politicians and power brokers that have come under their influence are exposed as the events of “Russiagate” are reported publicly.

And that exposure can’t come quickly enough as news reports are now occurring about Australian and other children overseas, dying from the effects of unsafe vaccination products.
These stories are contained in this edition’s column titled The Safe Vaccine Debate.

A recent item in the Pharmacy Guild of Australia (PGA) publication Forefront  refers to an article published recently by i2P under the title of Countdown as Australian Pharmacy Begins the Transition as Part of a Global Network .
It seems to have touched a nerve, as they defensively comment:
“The decision by Chemist Warehouse to switch wholesalers and the purchase of PillPack by Amazon in the US seem to have woken the community pharmacy doom-and-gloom merchants from their slumber.”
i2P responds that far from being asleep at the wheel, we actually keep an ongoing file regarding globalism and Australian community pharmacy, and develop opinion articles based on events and evidence as it evolves.
This is delivered to interested pharmacists so that they can strategically plan and strengthen their business models.
In that context it should be apparent that i2P is highly supportive to the survival of community pharmacy and we do not promote “demise” thinking.
But we do promote change in leadership culture to ensure that a strong business model emerges to cope with global challenges.

The recent article referred to was triggered by the Chemist Warehouse/Sigma parting of the ways, because i2P had predicted that eventual outcome, even the identity of the new Chemist Warehouse supplier, Symbion – twelve months ago.
i2P competes in a thought leadership capacity and does set out to challenge other pharmacy thought leadership organisations.
We can at least say that we have awakened the PGA to some of the possibilities that may eventuate so that they can thoughtfully fulfill their brief of ensuring that community pharmacy does survive.
PGA culture has gradually evolved from a very disruptive culture, but is far from being a fully collaborative culture engaging with all sectors of pharmacy.

i2P is highly critical of PGA in not collaborating with independent clinical service contractors, by not placing them and nurturing them front and centre, inside community pharmacies.
They represent a “core component” of community pharmacy and the pathway to a permanent future.
They also represent opportunity because they are independent businesses – potential members of a reinvigorated and forward-looking PGA, culturally aligned to truly generate community pharmacy survival.
That is the type of permanency that would ensure the future prosperity of a strong pharmacy profession.
And that needs to happen urgently, along with other associated activities, such as prescribing, self-care systemisation, and a minor ailments program – all associated with each other for efficient delivery.
We will be touching on all of these activities in future editions of i2P

Other countries, particularly the UK, have long embraced pharmacist prescribing.
Australia does have non-medical prescribers (dependent and independent), but they do not include pharmacists as yet.
And this is a clinical activity that needs to be driven by pharmacist leadership organisations – so PGA needs to get on with the job of ensuring community pharmacy survival.
The dependent version of prescribing would have low potential for conflict of interest but the independent version has a high potential for conflict of interest.
Hence the need for community pharmacy to embrace clinical service contractors in an “arms-length capacity” so that dependent prescribing in particular, can function without a conflict of interest potential.

The lead story in this edition concerns Self-Care and the need for its systemisation.
Self-Care has been around for a long time, with pharmacy being one of the first of the health professions to recognise and adopt the concept to the extent that it represents “core business”.
It embraces the idea that a patient is encouraged to take responsibility for their own health and wellbeing.
This is accompanied through the patient raising their own levels of health literacy, gaining knowledge from news media, publications, the Internet and reference libraries.
One other important knowledge source is a health professional, in particular a pharmacist, providing health literacy services – otherwise described as “patient engagement”.
Self-Care not only empowers the patient, but in systemising the concept it can lead into other pharmacy programs such as prescribing and a “minor ailments” clinical service.
It is a concept worth developing because it ensures pharmacy survival.
Read: Self-Care….A Perfect Fit with Community Pharmacy

Gerald Quigley is back with an article reinforcing why pharmacists should embrace International Self-Care Day and become involved with a major pharmacy opportunity.
i2P has often promoted the idea of pharmacists mentoring patients by providing Health Literacy services (paid and unpaid) which goes to the heart of creating a system for Self-Care.
Systemisation promotes Self-Care visibility and recognition.
Pharmacy is its natural home.
Read: International Self-Care Day – an Opportunity to Embrace

“The science is settled”.
So say the people who promote vaccination as some form of extreme medical ideology.
“Scientism is settled” is a more accurate description of the manipulation of the science surrounding vaccines – and it is certainly “unsettling” to hear the dishonest claims that blare out in all forms of media.
“First do no harm” is the concept that underwrites all medical practice.
Australian vaccination policy is so poor and damaging, that it beggars belief that legislators can be so close to manufacturer sales objectives as to guarantee them a market through coercive legislation that involves simultaneous removal of patient choice.
The evidence supporting vaccine policy failure and its lack of safety is becoming so voluminous that it will eventually destroy the unnatural power alliance that desperately tries to hold it all together.
Read: The Safe Vaccine Debate – 1. Dr Judy Wilyman: Newsletters #203 and #204 2. AVN: Two children die in Samoa minutes after MMR vaccination 3. GreenMedInfo: NVIC Tracking 134 Vaccine Bills Introduced in 35 States

WHO has made a statement saying that cannabis should be decriminalised world-wide because existing laws cause health discrimination.
In Australia, patients are being actively discriminated against as police are instructed to enforce existing laws and close down “illegal” supplies, leaving critically ill people with no workable solutions for their health problems.
Flawed health policy generates bad laws and lowered community respect for policy and laws.
Yet again, Pharmacy is in a position to provide solutions very simply and simultaneously create opportunity for the profession to treat chronically ill patients efficiently and economically.
Pharmacy leaders need to be proactive in the regulatory area because other health professionals are actively competing to lock pharmacy out of any opportunity whatsoever.
Potential for pharmacists is found in the compounding of THC and CBD in specific ratios to match the best result for patients with chronic illness.
Further pharmacist potential also lies in using cannabinoids in harm minimisation programs involving opioid dependencies and as an adjunct for the management of pain.
Pharmacists also need to be active and have a voice in the regulation of these substances ensuring that maximum patient access can be obtained through the application of Schedule 3 of the Poison’s Act.
Read: Understanding Medical Cannabis – 1. Cannabis Tech:Evolution Of Ethanol Extraction 2. Medical Marijuana News: Cannabis Consumers Opting For Edibles Rather Than Smokable Products, Report Suggests 3. ABC News: Cannabis chemical THC could be missing ‘piece to the puzzle’ in treating kids with epilepsy

Part of the Global Pharma marketing model is to promote the idea that new diseases are emerging as variants of existing diseases.
And of course, the new drugs additionally required to treat these so-called new diseases.
Jon Rappoport provides the background as to how side effects from drugs used to treat young children for ADHD have resulted in the supposed condition of bipolar disorder.
When will the regulators do their job?
Read: The secret behind fake bipolar disease in children

Getting through a stressful day is par for the course these days as business becomes more complex, creating feelings of anxiety when things simply don’t go well.
Harvey Mackay illustrates a day gone wrong in the life of a female airline passenger just about to board her flight and how things fell apart.
He describes how better control of emotions may have resulted in a better outcome.
Read: Calm Your Emotions  Before They Get Out Of Control

We conclude our offering for this edition by publishing media releases from three pharmacy leadership organisations:

PSA – PSA Media Releases – Pharmacists welcome leaps forward in digital health and cancer treatment

ASMI – ASMI Media Releases – ASMI proud to be part of Health Care Ethical Framework

NPS – NPS Media Releases – Medicinewise Update

We hope you enjoy reading this current edition. Please join the debate triggered by any article published in i2P by entering comment in the panel provided at the foot of each article page.

Neil Johnston
Editor, i2P E-Magazine
Monday 23 July 2018